欧米プロトロンビン複合体（PCC）製剤販売市場レポート 2022年版

Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Report 2022

市場分析・洞察：欧州と米国のプロトロンビン複合体（PCC）製剤市場 COVID-19の流行により、欧州および米国のプロトロンビン複合体（PCC）医薬品市場規模は、2022年に6億7470万米ドルと推定され、レビュー期間中... もっと見る

drug

出版社	出版年月	電子版価格	言語
QYResearch QYリサーチ	2023年1月6日	US$3,350 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

市場分析・洞察：欧州と米国のプロトロンビン複合体（PCC）製剤市場
COVID-19の流行により、欧州および米国のプロトロンビン複合体（PCC）医薬品市場規模は、2022年に6億7470万米ドルと推定され、レビュー期間中のCAGRは11.76%で2028年までに1億3168万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年にプロトロンビン複合体製剤（PCC）欧州および米国市場の68.2％を占めるベリプレックスは、2028年までに887百万米ドルの価値を持ち、COVID-19後の期間においてCAGR 11.52% で改定成長すると予測されます。
欧州と米国では、プロトロンビン複合体（PCC）製剤の主要メーカーには、CSLベーリング、Grifols、Octapharma、Prothya Biosolutions、武田薬品があります。2021年、欧州と米国の上位5社のシェアは、売上高で約98％となっています。

欧米プロトロンビン複合体濃縮製剤（PCC）の薬剤の範囲とセグメント
プロトロンビン複合体（PCC）医薬品市場は、タイプ別、用途別に分類されています。欧州と米国のプロトロンビン複合体（PCC）医薬品市場のプレイヤー、関係者、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、タイプ別、アプリケーション別の売上、収益、予測に焦点を当て、2017年から2028年の期間について説明します。

会社別
CSL ベーリング
グリフォルス
オクタファーマ
プロティア・バイオソリューションズ
武田

タイプ別セグメント
ベリプレックス
プロフィルナイン
オクタプレックス
プロトロムプレックス
コファクト
その他

用途別セグメント
ヘモフィリアB
後天性凝固因子欠乏症（こうてんせいこうそけつぼうしょう
その他

国・地域別セグメント
ユーエスエー
ドイツ
フランス
連邦王国
イタリア
スペイン
ネーデルラント
その他の国

ページTOPに戻る

1 STUDY COVERAGE 1
1.1 Prothrombin Complex Concentrate (PCC) Drug Product Introduction 1
1.2 Market by Type 1
1.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1
1.2.2 Cofact 4
1.2.3 Beriplex 5
1.2.4 Profilnine 6
1.2.5 Octaplex 7
1.2.6 Prothromplex 8
1.3 Market by Application 8
1.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 9
1.3.2 Hemophilia B 11
1.3.3 Acquired Coagulation Factor Deficiency 12
1.4 Study Objectives 12
1.5 Years Considered 13
2 EXECUTIVE SUMMARY 14
2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Estimates and Forecasts 2017-2028 14
2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Estimates and Forecasts 2017-2028 15
2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2017 VS 2021 VS 2028 17
2.4 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country 18
2.4.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) 18
2.4.2 Europe and United States Sales Prothrombin Complex Concentrate (PCC) Drug by Country (2023-2028) 20
2.5 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country 22
2.5.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) 22
2.5.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2023-2028) 23
2.6 Germany 24
2.7 France 25
2.8 UK 26
2.9 Italy 27
2.10 Spain 28
2.11 Netherland 29
2.12 United States 30
2.13 Other Countries 31
3 COMPETITION BY MANUFACTURERS 33
3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers 33
3.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers (2017-2022) 33
3.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2017-2022) 34
3.1.3 Europe and United States Top Largest Manufacturers of Prothrombin Complex Concentrate (PCC) Drug in 2021 34
3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers 35
3.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers (2017-2022) 35
3.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2017-2022) 36
3.2.3 Europe and United States Top Companies by Prothrombin Complex Concentrate (PCC) Drug Revenue in 2021 36
3.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Price by Manufacturers (2017-2022) 37
3.4 Analysis of Competitive Landscape 38
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 38
3.4.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) 39
3.4.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Manufacturers Geographical Distribution 39
3.5 Mergers & Acquisitions, Expansion Plans 41
4 MARKET SIZE BY TYPE 43
4.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type 43
4.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Sales by Type (2017-2022) 43
4.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Sales by Type (2023-2028) 43
4.1.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028) 44
4.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type 45
4.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Revenue by Type (2017-2022) 45
4.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Revenue by Type (2023-2028) 46
4.2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028) 46
4.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Type 48
4.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Type (2017-2022) 48
4.3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2023-2028) 48
5 MARKET SIZE BY APPLICATION 50
5.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application 50
5.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Sales by Application (2017-2022) 50
5.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Sales by Application (2023-2028) 50
5.1.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028) 51
5.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application 52
5.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Revenue by Application (2017-2022) 52
5.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Revenue by Application (2023-2028) 53
5.2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028) 53
5.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Application 54
5.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Application (2017-2022) 54
5.3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Application (2023-2028) 55
6 GERMANY 56
6.1 Germany Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 56
6.1.1 Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 56
6.1.2 Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 57
6.2 Germany Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 59
6.2.1 Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 59
6.2.2 Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 60
7 FRANCE 62
7.1 France Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 62
7.1.1 France Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 62
7.1.2 France Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 63
7.2 France Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 65
7.2.1 France Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 65
7.2.2 France Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 66
8 UK 68
8.1 UK Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 68
8.1.1 UK Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 68
8.1.2 UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 69
8.2 UK Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 71
8.2.1 UK Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 71
8.2.2 UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 72
9 ITALY 74
9.1 Italy Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 74
9.1.1 Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 74
9.1.2 Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 75
9.2 Italy Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 77
9.2.1 Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 77
9.2.2 Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 78
10 SPAIN 80
10.1 Spain Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 80
10.1.1 Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 80
10.1.2 Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 81
10.2 Spain Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 83
10.2.1 Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 83
10.2.2 Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 84
11 NETHERLAND 86
11.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 86
11.1.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 86
11.1.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 87
11.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 89
11.2.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 89
11.2.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 90
12 UNITED STATES 92
12.1 United States Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 92
12.1.1 United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 92
12.1.2 United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 93
12.2 United States Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 95
12.2.1 United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 95
12.2.2 United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 96
13 OTHER COUNTRIES 98
13.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Market Size by Type 98
13.1.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028) 98
13.1.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028) 99
13.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Market Size by Application 101
13.2.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028) 101
13.2.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028) 102
14 CORPORATE PROFILE 104
14.1 CSL Behring 104
14.1.1 CSL Behring Corporation Information 104
14.1.2 CSL Behring Overview 105
14.1.3 CSL Behring in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022) 105
14.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 106
14.1.5 CSL Behring Recent Developments 107
14.2 Grifols 108
14.2.1 Grifols Corporation Information 108
14.2.2 Grifols Overview 108
14.2.3 Grifols in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022) 109
14.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 109
14.2.5 Grifols Recent Developments 110
14.3 Octapharma 111
14.3.1 Octapharma Corporation Information 111
14.3.2 Octapharma Overview 111
14.3.3 Octapharma in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022) 112
14.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 112
14.3.5 Octapharma Recent Developments 113
14.4 Prothya Biosolutions 114
14.4.1 Prothya Biosolutions Corporation Information 114
14.4.2 Prothya Biosolutions Overview 115
14.4.3 Prothya Biosolutions in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022) 116
14.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 116
14.5 Takeda 117
14.5.1 Takeda Corporation Information 117
14.5.2 Takeda Overview 118
14.5.3 Takeda in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022) 118
14.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications 119
14.5.5 Takeda Recent Developments 119
15 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 121
15.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis 121
15.2 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials 122
15.2.1 Key Raw Materials 122
15.2.2 Raw Materials Key Suppliers 123
15.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process 124
15.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing 126
15.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels 126
15.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors 127
15.5 Prothrombin Complex Concentrate (PCC) Drug Customers 130
16 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET DYNAMICS 133
16.1.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends 133
16.1.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers 136
16.1.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges 137
16.1.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints 138
17 KEY FINDINGS IN THE EUROPE AND UNITED STATES PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG STUDY 139
18 APPENDIX 141
18.1 Research Methodology 141
18.1.1 Methodology/Research Approach 141
18.1.2 Data Source 145
18.2 Author Details 149
18.3 Disclaimer 149

ページTOPに戻る

Table of Contents

Summary

Market Analysis and Insights: Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market
Due to the COVID-19 pandemic, the Europe and United States Prothrombin Complex Concentrate (PCC) Drug market size is estimated to be worth US$ 674.7 million in 2022 and is forecast to a readjusted size of US$ 1314.68 million by 2028 with a CAGR of 11.76% during the review period. Fully considering the economic change by this health crisis, Beriplex accounting for 68.2% of the Prothrombin Complex Concentrate (PCC) Drug Europe and United States market in 2021, is projected to value US$ 887 million by 2028, growing at a revised 11.52% CAGR in the post-COVID-19 period.
In Europe and United States, the key manufacturers of Prothrombin Complex Concentrate (PCC) Drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, and Takeda. In 2021, the Europe and United States top five players have a share approximately 98% in terms of revenue.

Europe and United States Prothrombin Complex Concentrate (PCC) Drug Scope and Segment
Prothrombin Complex Concentrate (PCC) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the Europe and United States Prothrombin Complex Concentrate (PCC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda

Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other

Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Others

Segment by Country/Region
United States
Germany
France
UK
Italy
Spain
Netherland
Other Countries

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

欧米プロトロンビン複合体（PCC）製剤販売市場レポート 2022年版

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?